DNA damage induces p21 protein expression by inhibiting ubiquitination in ML-1 cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1404, Issue 3, 1998, Pages 405-411

  Fukuchi, Kunihiko ^a   Tomoyasu, Shigeru ^a   Nakamaki, Tsuyoshi ^a   Tsuruoka, Nobuyoshi ^a   Gomi, Kunihide ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Deferoxamine; DNA damage; p21; Proteasome; Ubiquitin

Indexed keywords

DEFEROXAMINE; PROTEASOME; PROTEIN P21; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; TRANSCRIPTION REGULATION;

ACETYLCYSTEINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYSTEINE PROTEINASE INHIBITORS; CYTARABINE; DEFEROXAMINE; DNA DAMAGE; ETOPOSIDE; GENE EXPRESSION REGULATION; HYDROXYUREA; POLYRIBOSOMES; RNA, MESSENGER; TUMOR CELLS, CULTURED; UBIQUITINS;

EID: 18144449038     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(98)00089-5     Document Type: Article

References (44)

1. [1] C.J. Sherr, G1 phase progression: cycling on cue, Cell 79 (1994) 551-555.
2. [2] C.J. Sherr, J.M. Roberts, Inhibitors of mammalian G1 cyclin-dependent kinases, Genes Dev. 9 (1995) 1149-1163.
3. [3] W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parson, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression, Cell 75 (1993) 817-825.
4. [4] Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, D. Beach, p21 is a universal inhibitor of cyclin kinases, Nature 366 (1993) 701-704.
5. [5] W.S. El-Deiry, J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler, B. Vogelstein, WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis, Cancer Res. 54 (1994) 1169-1174.
6. [6] K.F. Macleod, N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, T. Jacks, p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage, Genes Dev. 9 (1995) 935-944.
7. [7] R.A. Steinman, B. Hoffman, A. Iro, C. Guillouf, D.A. Liebermann, M.E. El-Houseini, Induction of p21 (WAF1/CIP1) during differentiation, Oncogene 9 (1994) 3389-3396.
8. [8] W. Zhang, L. Grasso, C.D. McClain, A.M. Gambel, Y. Cha, S. Travali, A.B. Deisseroth, W.E. Mercer, p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation, Cancer Res. 55 (1995) 668-674.
9. [9] H. Jiang, J. Lin, Z.-Z. Su, F.R. Collart, E. Huberman, P.B. Fisher, Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53, Oncogene 9 (1994) 3397-3406.
10. [10] P. Michieli, M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, D. Givol, Induction of WAF1/CIP1 by a p53-independent pathway, Cancer Res. 54 (1994) 3391-3395.
11. [11] M.S. Sheikh, X.-S. Li, J.-C. Chen, Z.-M. Shao, J.V. Ordonez, J.A. Fontana, Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction, Oncogene 9 (1994) 3407-3415.
12. [12] M. Johnson, D. Dimitrov, P.J. Vojta, J.C. Barrett, A. Noda, O.M. Pereira-Smith, J.R. Smith, Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/ p21 RNA in human cells, Mol. Carcinog. 11 (1994) 59-64.
13. [13] O. Halevy, B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, A.B. Lassar, Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD, Science 267 (1995) 1018-1021.
14. [14] M.B. Datto, Y. Li, J.F. Panus, D.J. Howe, Y. Xiong, X.-F. Wang, Transforming growth factor (beta) induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism, Proc. Natl. Acad. Sci. USA 92 (1995) 5545-5549.
15. [15] M. Liu, M.H. Lee, M. Cohen, M. Bommakanti, L.P. Freedman, Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937, Genes Dev. 10 (1996) 143-153.
16. [16] M. Liu, A. Iavarone, L.P. Freedman, Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor, J. Biol. Chem. 271 (1996) 31723-31728.
17. [17] A.C. Hobeika, P.S. Subramaniam, H.M. Johonson, IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells, Oncogene 14 (1997) 1165-1170.
18. [18] J. Schwaller, H.P. Koeffler, G. Niklaus, P. Loetscher, S. Nagel, M.F. Fey, A. Tobler, Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/ SDI1 in differentiating human leukemic cells, J. Clin. Invest. 95 (1995) 973-979.
19. [19] M. Shiohara, M. Akashi, A.F. Gombart, R. Yang, H.P. Koeffler, Tumor necrosis factor α: posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells, J. Cell Physiol. 166 (1996) 568-576.
20. [20] Y.-X. Zeng, W.S. El-Deiry, Regulation of p21WAF1/CIP1 expression by p53-independent pathways, Oncogene 12 (1996) 1557-1564.
21. [21] M. Glotzer, A.W. Murray, M.W. Kirschner, Cyclin is degraded by the ubiquitin pathway, Nature 349 (1991) 132-138.
22. [22] M. Pagano, S.W. Tam, A.M. Theodoras, P. Beer-Romero, G.D. Sal, V. Chau, P.R. Yew, G.F. Draetta, M. Rolfe, Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27, Science 269 (1995) 682-685.
23. [23] M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, P.M. Howley, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell 63 (1990) 1129-1136.
24. [24] J. Mosner, T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, W. Deppert, Negative feedback regulation of wild-type p53 biosynthesis, EMBO J. 14 (1995) 4442-4449.
25. [25] C.G. Maki, J.M. Huibregtse, P.M. Howley, In vivo ubiquitination and proteasome-mediated degradation of p53, Cancer Res. 56 (1996) 2649-2654.
26. [26] C.G. Maki, P.M. Howley, Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation, Mol. Cell. Biol. 17 (1997) 355-363.
27. [27] U.G. Lopes, P. Erhardt, R. Yao, G.M. Cooper, p53-dependent induction of apoptosis by proteasome inhibitors, J. Biol. Chem. 272 (1997) 12893-12896.
28. [28] M.V. Blagosklonny, G. Sheng, S. Omura, W.S. El-Deiry, Proteasome-dependent regulation of p21WAF1/CIP1 expression, Biochem. Biophys. Res. Commun. 227 (1996) 564-569.
29. [29] A.V. Hoffbrand, K. Ganeshaguru, J.M.L. Hooton, M.H.N. Tattersall, Effect of iron deficiency and desferrioxamine of DNA synthesis in human cells, Br. J. Haematol. 33 (1976) 517-526.
30. [30] K. Fukuchi, S. Tomoyasu, H. Watanabe, S. Kaetsu, N. Tsuruoka, K. Gomi, Iron deprivation results in an increase in p53 expression, Biol. Chem. 376 (1995) 627-630.
31. [31] K. Fukuchi, S. Tomoyasu, H. Watanabe, N. Tsuruoka, K. Gomi, G1 accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells, Biochim. Biophys. Acta 1357 (1997) 297-305.
32. [32] J.M. van Maanen, J. Retel, J. de Vries, H.M. Pinedo, Mechanism of action of antitumor drug etoposide: a review, J. Natl. Cancer Inst. 80 (1988) 1526-1533.
33. [33] S.S. Cohen, The mechanism of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA), Cancer 40 (1977) 509-518.
34. [34] S. Omura, T. Fujimoto, K. Otoguro, R. Matsuzaki, R. Moriguchi, H. Tanaka, Y. Sasaki, Lactacystin, a novel microbial metabolites, induces neutrogenesis of neuroblastoma cells, J. Antibiot. 44 (1991) 113-116.
35. [35] J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: a Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
36. [36] Y. Haupt, R. Maya, A. Kazaz, M. Oren, Mdm promotes the rapid degradation of p53, Nature 387 (1997) 296-299.
37. [37] M.H.G. Kubbutat, S.N. Jones, K.H. Vousden, Regulation of p53 stability by Mdm2, Nature 378 (1997) 299-303.
38. [38] R. Baskaran, L.D. Wood, L.L. Whitaker, C.E. Canman, S.E. Morgan, Y. Xu, C. Barlow, D. Baltimore, A. Wynshaw-Boris, M.B. Kasten, J.Y.J. Wang, Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation, Nature 387 (1997) 516-519.
39. [39] T. Shafman, K.K. Khanna, P. Kedar, K. Spring, S. Kozlov, T. Yen, K. Hobson, M. Gatei, N. Zhang, D. Watters, M. Egerton, Y. Shiloh, S. Kharbanda, D. Kufe, M.F. Lavin, Interaction between ATM protein and c-Abl in response to DNA damage, Nature 387 (1997) 520-523.
40. [40] S. Kharbanda, P. Pandey, S. Jin, S. Inoue, A. Bharti, Z.-M. Yuan, R. Weichselbaum, D. Weaver, D. Kufe, Functional interaction between DNA-PK and c-Abl in response to DNA damage, Nature 386 (1997) 732-735.
41. [41] A. Alessandrini, D.S. Chiaur, M. Pagano, Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation, Leukemia 11 (1997) 342-345.
42. [42] S.Y. Fuchs, L. Dolan, R.J. Davis, Z. Ronai, Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase, Oncogene 13 (1996) 1531-1535.
43. [43] Z. Chen, J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, T. Maniatis, Signal-induced site-specific phosphorylation targets IκBβ to the ubiquitin-proteasome pathway, Genes Dev. 9 (1995) 1586-1597.
44. [44] T.K. Kim, T. Maniatis, Regulation of interferon-γ-activated STAT1 by the ubiquitin-proteasome pathway, Science 273 (1996) 1717-1719.